drugset / Trial / NCT06854406

A Study of Varenicline in the Treatment of Visceral Sensation

NCT06854406

Phase 1 Completed 8 enrolled Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of varenicline on rectal sensation, based on ascending method of limits and on graded rapid phasic distensions in participants with non-constipation IBS and chronic abdominal pain.

Timeline

Start
2025-06-01
Primary completion
2025-11-30
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg Oral